Newsroom | 23509 results

RICHARDSON, Texas--(BUSINESS WIRE)--Healthcare data analytics leader MedeAnalytics and agentic AI innovator Basys.ai announced a strategic partnership that will benefit health payers....

MALVERN, Pa.--(BUSINESS WIRE)--LifeScan (the “Company”), a world leader in blood glucose monitoring, today announced its successful emergence from its Chapter 11 financial restructuring process following approval of its Plan of Reorganization on October 27, 2025. Through this process, the Company eliminated more than 75% of its debt, providing the financial flexibility needed to continue its leadership in the glucose management industry. In connection with emergence, LifeScan is now owned by a...

BROOMFIELD, Colo.--(BUSINESS WIRE)--Swisslog Healthcare now brings to market Allegro™, a new automated and high-density inventory solution designed to maximize pharmacy efficiency to the US market. The system made its industry debut at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in early December, where pharmacy professionals witnessed its capabilities firsthand. The most flexible, highly sophisticated model in Swisslog Healthcare's inventory management por...

SAN DIEGO--(BUSINESS WIRE)--Powered by Rheo, ChiroTouch’s new Compliance Scan uses AI to review documentation, reduce claim denials, and protect chiropractors from audit risk....

LONDON & CHICAGO--(BUSINESS WIRE)--Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to improving the conduct of clinical trials, today announced the completion of enrollment of 550+ patients at 50+ sites for a single study in just six months, using it’s proprietary AnovaOS™ Platform. The program provided cancer doctors and patients with a promising treatment that was otherwise unavailable. The sponsor was provided with safety and efficacy data to support its drug development...

EVANSTON, Ill.--(BUSINESS WIRE)--Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the Harvey Prize in Science and Technology. The prestigious international prize, awarded by the Technion, Israel Institute of Technology in Haifa, recognizes Professor Mirkin for groundbreaking discoveries that have fundamentally reshaped the fields of nanoscience and nanote...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis® , a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, today announced the signing of a non-exclusive global commercial distribution agreement...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, éligible PEA/PME, « Median » ou « La Société »), fabricant d’eyonis®, une suite de logiciels dispositifs médicaux basés sur l’intelligence artificielle (IA) pour le diagnostic précoce des cancers, et un leader mondial de la fourniture d’analyses d’images par IA et de services centraux d’imagerie pour les essais cliniques en oncologie de l’industrie biopharmaceutique, annonce aujourd’hui la sign...

AUSTIN, Texas--(BUSINESS WIRE)--Everlywell, a leader in digital health, today reported new insights from Eva Engage, the personalized outreach capability within Eva, its AI health companion launched earlier this year. Eva is powered by three core engines, Eva Engage, Eva Care, and Eva Support, that create an intelligent, connected care experience, helping individuals take meaningful action for their health. Eva Engage is more proactive, timely, and deeply personal than traditional outreach. Its...

BARCELONA, Spain--(BUSINESS WIRE)--REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company focused on advancing precision oncology through biomarker innovation, announced today the presentation of seven studies at the upcoming San Antonio Breast Cancer Symposium (SABCS) 2025, held December 9–12 in San Antonio, Texas. These abstracts showcase the growing clinical utility and innovation of the company’s proprietary RNA platform and underscore REVEAL GENOMICS’ commitment to improving outcom...